Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc. WBA Peers
See (WBA) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| WBA | $11.49 | +0.00% | 9.9B | -1.58 | -$7.29 | +4.36% |
| ONC | $244.32 | -0.34% | 24.2B | -67.23 | -$3.63 | N/A |
| INSM | $98.24 | +0.64% | 18.7B | -16.55 | -$5.94 | N/A |
| HROWL | $25.51 | -0.06% | 1.2B | N/A | N/A | N/A |
| HROWM | $26.58 | +0.00% | 1.1B | N/A | N/A | +11.16% |
| LFMDP | $24.25 | +0.00% | 1.1B | -10.75 | -$2.26 | N/A |
| LFMD | $12.93 | -1.52% | 587M | -39.14 | -$0.33 | N/A |
| HITI | $2.34 | +1.74% | 190M | -26.06 | -$0.09 | N/A |
| PETS | $3.37 | +3.06% | 70.2M | 340.00 | $0.01 | N/A |
| YI | $7.34 | +3.53% | 63.6M | -3.38 | -$2.17 | N/A |
Stock Comparison
WBA vs ONC Comparison
WBA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WBA stands at 9.9B. In comparison, ONC has a market cap of 24.2B. Regarding current trading prices, WBA is priced at $11.49, while ONC trades at $244.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WBA currently has a P/E ratio of -1.58, whereas ONC's P/E ratio is -67.23. In terms of profitability, WBA's ROE is -0.70%, compared to ONC's ROE of -0.12%. Regarding short-term risk, WBA is less volatile compared to ONC. This indicates potentially lower risk in terms of short-term price fluctuations for WBA.
WBA vs INSM Comparison
WBA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WBA stands at 9.9B. In comparison, INSM has a market cap of 18.7B. Regarding current trading prices, WBA is priced at $11.49, while INSM trades at $98.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WBA currently has a P/E ratio of -1.58, whereas INSM's P/E ratio is -16.55. In terms of profitability, WBA's ROE is -0.70%, compared to INSM's ROE of -4.47%. Regarding short-term risk, WBA is less volatile compared to INSM. This indicates potentially lower risk in terms of short-term price fluctuations for WBA.
WBA vs HROWL Comparison
WBA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WBA stands at 9.9B. In comparison, HROWL has a market cap of 1.2B. Regarding current trading prices, WBA is priced at $11.49, while HROWL trades at $25.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WBA currently has a P/E ratio of -1.58, whereas HROWL's P/E ratio is N/A. In terms of profitability, WBA's ROE is -0.70%, compared to HROWL's ROE of -0.36%. Regarding short-term risk, WBA is more volatile compared to HROWL. This indicates potentially higher risk in terms of short-term price fluctuations for WBA.
WBA vs HROWM Comparison
WBA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WBA stands at 9.9B. In comparison, HROWM has a market cap of 1.1B. Regarding current trading prices, WBA is priced at $11.49, while HROWM trades at $26.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WBA currently has a P/E ratio of -1.58, whereas HROWM's P/E ratio is N/A. In terms of profitability, WBA's ROE is -0.70%, compared to HROWM's ROE of -0.28%. Regarding short-term risk, WBA is less volatile compared to HROWM. This indicates potentially lower risk in terms of short-term price fluctuations for WBA.
WBA vs LFMDP Comparison
WBA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WBA stands at 9.9B. In comparison, LFMDP has a market cap of 1.1B. Regarding current trading prices, WBA is priced at $11.49, while LFMDP trades at $24.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WBA currently has a P/E ratio of -1.58, whereas LFMDP's P/E ratio is -10.75. In terms of profitability, WBA's ROE is -0.70%, compared to LFMDP's ROE of +2.33%. Regarding short-term risk, WBA is more volatile compared to LFMDP. This indicates potentially higher risk in terms of short-term price fluctuations for WBA.
WBA vs LFMD Comparison
WBA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WBA stands at 9.9B. In comparison, LFMD has a market cap of 587M. Regarding current trading prices, WBA is priced at $11.49, while LFMD trades at $12.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WBA currently has a P/E ratio of -1.58, whereas LFMD's P/E ratio is -39.14. In terms of profitability, WBA's ROE is -0.70%, compared to LFMD's ROE of +2.33%. Regarding short-term risk, WBA is less volatile compared to LFMD. This indicates potentially lower risk in terms of short-term price fluctuations for WBA.
WBA vs HITI Comparison
WBA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WBA stands at 9.9B. In comparison, HITI has a market cap of 190M. Regarding current trading prices, WBA is priced at $11.49, while HITI trades at $2.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WBA currently has a P/E ratio of -1.58, whereas HITI's P/E ratio is -26.06. In terms of profitability, WBA's ROE is -0.70%, compared to HITI's ROE of -0.05%. Regarding short-term risk, WBA is less volatile compared to HITI. This indicates potentially lower risk in terms of short-term price fluctuations for WBA.
WBA vs PETS Comparison
WBA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WBA stands at 9.9B. In comparison, PETS has a market cap of 70.2M. Regarding current trading prices, WBA is priced at $11.49, while PETS trades at $3.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WBA currently has a P/E ratio of -1.58, whereas PETS's P/E ratio is 340.00. In terms of profitability, WBA's ROE is -0.70%, compared to PETS's ROE of +0.00%. Regarding short-term risk, WBA is less volatile compared to PETS. This indicates potentially lower risk in terms of short-term price fluctuations for WBA.
WBA vs YI Comparison
WBA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WBA stands at 9.9B. In comparison, YI has a market cap of 63.6M. Regarding current trading prices, WBA is priced at $11.49, while YI trades at $7.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WBA currently has a P/E ratio of -1.58, whereas YI's P/E ratio is -3.38. In terms of profitability, WBA's ROE is -0.70%, compared to YI's ROE of +0.11%. Regarding short-term risk, WBA is less volatile compared to YI. This indicates potentially lower risk in terms of short-term price fluctuations for WBA.
WBA vs RAD Comparison
WBA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WBA stands at 9.9B. In comparison, RAD has a market cap of 36.8M. Regarding current trading prices, WBA is priced at $11.49, while RAD trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WBA currently has a P/E ratio of -1.58, whereas RAD's P/E ratio is -0.05. In terms of profitability, WBA's ROE is -0.70%, compared to RAD's ROE of +2.76%. Regarding short-term risk, WBA is less volatile compared to RAD. This indicates potentially lower risk in terms of short-term price fluctuations for WBA.
WBA vs RNTX Comparison
WBA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WBA stands at 9.9B. In comparison, RNTX has a market cap of 33.7M. Regarding current trading prices, WBA is priced at $11.49, while RNTX trades at $1.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WBA currently has a P/E ratio of -1.58, whereas RNTX's P/E ratio is -0.52. In terms of profitability, WBA's ROE is -0.70%, compared to RNTX's ROE of -0.80%. Regarding short-term risk, WBA is less volatile compared to RNTX. This indicates potentially lower risk in terms of short-term price fluctuations for WBA.
WBA vs MEDS Comparison
WBA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WBA stands at 9.9B. In comparison, MEDS has a market cap of 13.3M. Regarding current trading prices, WBA is priced at $11.49, while MEDS trades at $7.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WBA currently has a P/E ratio of -1.58, whereas MEDS's P/E ratio is -0.31. In terms of profitability, WBA's ROE is -0.70%, compared to MEDS's ROE of +0.22%. Regarding short-term risk, WBA is less volatile compared to MEDS. This indicates potentially lower risk in terms of short-term price fluctuations for WBA.
WBA vs NEUP Comparison
WBA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WBA stands at 9.9B. In comparison, NEUP has a market cap of 13.2M. Regarding current trading prices, WBA is priced at $11.49, while NEUP trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WBA currently has a P/E ratio of -1.58, whereas NEUP's P/E ratio is 0.37. In terms of profitability, WBA's ROE is -0.70%, compared to NEUP's ROE of +0.31%. Regarding short-term risk, WBA is less volatile compared to NEUP. This indicates potentially lower risk in terms of short-term price fluctuations for WBA.
WBA vs CJJD Comparison
WBA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WBA stands at 9.9B. In comparison, CJJD has a market cap of 9.9M. Regarding current trading prices, WBA is priced at $11.49, while CJJD trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WBA currently has a P/E ratio of -1.58, whereas CJJD's P/E ratio is -0.46. In terms of profitability, WBA's ROE is -0.70%, compared to CJJD's ROE of -0.30%. Regarding short-term risk, WBA is less volatile compared to CJJD. This indicates potentially lower risk in terms of short-term price fluctuations for WBA.
WBA vs SSY Comparison
WBA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WBA stands at 9.9B. In comparison, SSY has a market cap of 6.4M. Regarding current trading prices, WBA is priced at $11.49, while SSY trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WBA currently has a P/E ratio of -1.58, whereas SSY's P/E ratio is -2.32. In terms of profitability, WBA's ROE is -0.70%, compared to SSY's ROE of +0.12%. Regarding short-term risk, WBA is less volatile compared to SSY. This indicates potentially lower risk in terms of short-term price fluctuations for WBA.
WBA vs ATNFW Comparison
WBA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WBA stands at 9.9B. In comparison, ATNFW has a market cap of 4.6M. Regarding current trading prices, WBA is priced at $11.49, while ATNFW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WBA currently has a P/E ratio of -1.58, whereas ATNFW's P/E ratio is N/A. In terms of profitability, WBA's ROE is -0.70%, compared to ATNFW's ROE of -1.47%. Regarding short-term risk, WBA is less volatile compared to ATNFW. This indicates potentially lower risk in terms of short-term price fluctuations for WBA.
WBA vs MDVL Comparison
WBA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WBA stands at 9.9B. In comparison, MDVL has a market cap of 2.9M. Regarding current trading prices, WBA is priced at $11.49, while MDVL trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WBA currently has a P/E ratio of -1.58, whereas MDVL's P/E ratio is -0.05. In terms of profitability, WBA's ROE is -0.70%, compared to MDVL's ROE of -2.39%. Regarding short-term risk, WBA is less volatile compared to MDVL. This indicates potentially lower risk in terms of short-term price fluctuations for WBA.
WBA vs LFLYW Comparison
WBA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WBA stands at 9.9B. In comparison, LFLYW has a market cap of 1.4M. Regarding current trading prices, WBA is priced at $11.49, while LFLYW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WBA currently has a P/E ratio of -1.58, whereas LFLYW's P/E ratio is -0.18. In terms of profitability, WBA's ROE is -0.70%, compared to LFLYW's ROE of +0.34%. Regarding short-term risk, WBA is less volatile compared to LFLYW. This indicates potentially lower risk in terms of short-term price fluctuations for WBA.
WBA vs LFLY Comparison
WBA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WBA stands at 9.9B. In comparison, LFLY has a market cap of 875.3K. Regarding current trading prices, WBA is priced at $11.49, while LFLY trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WBA currently has a P/E ratio of -1.58, whereas LFLY's P/E ratio is -0.15. In terms of profitability, WBA's ROE is -0.70%, compared to LFLY's ROE of +0.34%. Regarding short-term risk, WBA is less volatile compared to LFLY. This indicates potentially lower risk in terms of short-term price fluctuations for WBA.
WBA vs BIMI Comparison
WBA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, WBA stands at 9.9B. In comparison, BIMI has a market cap of 1.4K. Regarding current trading prices, WBA is priced at $11.49, while BIMI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
WBA currently has a P/E ratio of -1.58, whereas BIMI's P/E ratio is N/A. In terms of profitability, WBA's ROE is -0.70%, compared to BIMI's ROE of -2.93%. Regarding short-term risk, WBA is more volatile compared to BIMI. This indicates potentially higher risk in terms of short-term price fluctuations for WBA.